Showing results (141-150 of 173) with videos related to
Sort By:
Pageof 18
BMC Pulmonary Medicine|October 22, 2024
Clinical characteristics, use and switch of drugs for obstructive airway diseases among patients with COPD experiencing an exacerbation: a retrospective analysis of Italian administrative healthcare dataLetizia Dondi, Giulia Ronconi, Silvia Calabria, et al.BMC Nephrology|March 17, 2024
Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016-2020Ursula Kirchmayer, Claudia Marino, Sandro Feriozzi, et al.Giornale Italiano Di Cardiologia (2006)|June 7, 2006
[Assessment of the absolute global cardiovascular risk: comparison between the risk chart and the individual score of the CUORE Project]Simona Giampaoli, Luigi Palmieri, Chiara Donfrancesco, et al.Journal of Clinical Medicine|June 2, 2021
Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort StudyValeria Belleudi, Alessandro C Rosa, Francesca R Poggi, et al.Frontiers in Pharmacology|July 12, 2021
The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and PerspectivesValeria Belleudi, Filomena Fortinguerra, Francesca R Poggi, et al.Journal of Clinical Medicine|June 19, 2024
Drug Use Patterns in Myasthenia Gravis: A Real-World Population-Based Cohort Study in ItalyMarco Finocchietti, Giada Crescioli, Olga Paoletti, et al.Frontiers in Oncology|June 27, 2022
Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian ProtocolNicola Silvestris, Valeria Belleudi, Antonio Addis, et al.European Journal of Neurology|September 19, 2024
Pharmacological and non-pharmacological treatments in amyotrophic lateral sclerosis: an Italian real-world data studyOlga Paoletti, Giulia Hyeraci, Marco Finochietti, et al.Clinical Drug Investigation|December 5, 2019
PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world StudyCarlo Piccinni, Ippazio Cosimo Antonazzo, Aldo P Maggioni, et al.Drug Safety|June 23, 2019
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort StudyValeria Belleudi, Francesco Trotta, Antonio Addis, et al.Pageof 18